Chenghui Li

High Impact

Associate Professor

Last publication 2025 Last refreshed 2026-05-16

faculty

Pharmacy Practice, College of Pharmacy

cli@uams.edu

23 h-index 177 pubs 1,952 cited

Biography and Research Information

OverviewAI-generated summary

Chenghui Li's research focuses on investigating the mechanisms and outcomes of various diseases and treatments, with a particular emphasis on cancer and infectious diseases. Li has published work examining the cardiotoxicity associated with immune checkpoint inhibitors and comparing survival rates for different treatments in non-small cell lung cancer patients with brain metastases. Additional research explores disparities in patient care experiences among prostate cancer survivors in rural versus urban settings.

Li's work also extends to virology, including the molecular detection and genetic characterization of Japanese encephalitis virus in animals and a metagenomic analysis of Togaviridae in mosquito viromes. This includes studies on the role of toll-like receptor 2 signaling in the inflammatory response to Japanese encephalitis virus in mouse microglial cells. Furthermore, Li has investigated the association between discontinuing chronic opioid therapy and the subsequent diagnosis of substance use disorders, accidents, and self-inflicted injuries.

With a highly cited designation, Li has authored 177 publications and accumulated over 1,952 citations, demonstrating a significant research output. Li leads a research group and collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Bradley C. Martin, Jacob T. Painter, Corey J. Hayes, and Jonathan Laryea.

Metrics

  • h-index: 23
  • Publications: 177
  • Citations: 1,952

Selected Publications

  • Poverty and Mortality Risk in Patients With Colorectal Cancer (2026)
  • Real-World Study Assessing Characteristics and Treatment Patterns of Patients With Human Epidermal Growth Factor Receptor 2 Immunohistochemistry 0 and Human Epidermal Growth Factor Receptor 2–Low Stage IV Breast Cancer: A Multicenter Retrospective Study (2026)
  • Impact of a minimally invasive approach for colon cancer surgery on outcomes in patients with functional limitations (2025)
    1 citation DOI OpenAlex
  • Colorectal cancer survival disparities in persistent poverty areas (2025)
    1 citation DOI OpenAlex
  • Bias in Prediction Models to Identify Patients With Colorectal Cancer at High Risk for Readmission After Resection (2024)
    1 citation DOI OpenAlex
  • Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases (2024)
    1 citation DOI OpenAlex
  • Sampling coverage of the Arkansas all‐payer claims database by County's persistent poverty designation (2024)
    2 citations DOI OpenAlex
  • Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations (2024)
    3 citations DOI OpenAlex
  • Maximizing Readmission Reduction in Colon Cancer Patients (2023)
    2 citations DOI OpenAlex
  • Food Insecurity and Health Outcomes of Children With Intellectual and Developmental Disabilities in the United States (2023)
    3 citations DOI OpenAlex
  • Heart Disease Knowledge and Awareness in African American and Hispanic Women (2023)
    4 citations DOI OpenAlex
  • Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases (2023)
    12 citations DOI OpenAlex
  • Differences in racial/ethnic disparities in patient care experiences between prostate cancer survivors and males without cancer: A SEER-CAHPS study (2023)
    3 citations DOI OpenAlex
  • Prior Pharmacy Work Experience as a Predictor of Clinical and Didactic Performance for Admissions Committees (2023)
    4 citations DOI OpenAlex
  • Rural–Urban Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study (2023)
    12 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

  • GLP-1 Based Therapies on Lymphedema in Overweight or Obese Breast Cancer Patients State of Arkansas - Pass Through: Arkansas Breast Cancer Research Program Principal Investigator
  • The Impact of Arkansas Medicaid Coverage Expansion and Change in Prior Authorization Procedure on Utilization of Tobacco Cessation Treatment among Ark Robert Wood Johnson Foundation Principal Investigator
  • Assessment of HER2-Low Testing Methods, Treatment Patterns and Clinical Outcomes in Advanced Breast Cancer: A Multicenter Chart Review Study AstraZeneca - Pass Through: University of Utah Principal Investigator
  • No FP attached University of Utah Principal Investigator
  • Affordable care act on racial disparity in endocrine therapy use among females with early stage hormone receptor positive breast cancer American Cancer Society, Inc. Principal Investigator
  • Assessment of HER2-Low Testing Methods, Treatment Patterns and Clinical Outcomes in Advanced Breast Cancer: A Multicenter Chart Review Study AstraZeneca - Pass Through: University of Utah Principal Investigator
  • No FP attached University of Utah Principal Investigator
  • Ambulatory Resource Utilization for Gout and Gouty Arthritis Flares NOVARTIS Pharmaceuticals Corporation Principal Investigator

Collaboration Network

205 Collaborators 69 Institutions 5 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics